Psychopharmacological interventions in autism spectrum disorder

@article{Accordino2016PsychopharmacologicalII,
  title={Psychopharmacological interventions in autism spectrum disorder},
  author={Robert E. Accordino and Christen L. Kidd and Laura C. Politte and Charles A Henry and Christopher J McDougle},
  journal={Expert Opinion on Pharmacotherapy},
  year={2016},
  volume={17},
  pages={937 - 952}
}
  • Robert E. Accordino, Christen L. Kidd, +2 authors Christopher J McDougle
  • Published 2016
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • ABSTRACT Introduction: Individuals with autism spectrum disorder (ASD) commonly present for treatment of emotional and behavioral disturbances associated with ASD’s “core” symptoms. Psychotropic medications are widely utilized in alleviating associated emotional and behavioral symptoms. Areas covered: Emotional and behavioral disturbances associated with ASD include irritability/severely disruptive behavior, which comprises the heaviest symptom burden; hyperactivity and other Attention-Deficit… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 48 CITATIONS, ESTIMATED 57% COVERAGE

    Pharmacologic treatment of obsessive-compulsive disorder comorbidity

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Animal models for autism in 2017 and the consequential implications to drug discovery

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Development of a patient-centered conceptual model of the impact of living with autism spectrum disorder

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2014
    2020

    CITATION STATISTICS

    • 1 Highly Influenced Citations

    • Averaged 10 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 166 REFERENCES

    Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.